Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells. [electronic resource]
Producer: 20060314Description: 296-302 p. digitalISSN:- 0145-2126
- ATP Binding Cassette Transporter, Subfamily B, Member 1 -- biosynthesis
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- pharmacology
- Antigens, CD34 -- biosynthesis
- Antineoplastic Agents -- immunology
- Apoptosis -- drug effects
- Biomarkers, Tumor -- biosynthesis
- Blast Crisis -- drug therapy
- Cell Line, Tumor
- Chromosome Aberrations
- Clinical Trials as Topic
- Cytarabine -- pharmacology
- Daunorubicin -- pharmacology
- Drug Evaluation, Preclinical
- Drug Resistance, Neoplasm -- drug effects
- Drug Synergism
- Female
- Humans
- Leukemia, Myeloid, Acute -- drug therapy
- Male
- Pilot Projects
- Receptors, Cytokine -- metabolism
- Stem Cell Factor -- antagonists & inhibitors
- Treatment Outcome
- bcl-2-Associated X Protein -- biosynthesis
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.